Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
S | Common Stock | D | 2218 | $41.12 - $41.67 | $91,693 |
| 2024-04-01 | SOLENO THERAPEUTICS INC | Mackaness James H
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 5175 | $41.12 - $41.67 | $213,936 |
| 2024-04-01 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
S | Common Stock | D | 2218 | $41.12 - $41.67 | $91,693 |
| 2024-04-01 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 18980 | $41.12 - $41.67 | $784,643 |
| 2024-01-25 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
S | Common Stock | D | 397 | $48.30 - $48.30 | $19,175 |
| 2024-01-25 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
S | Common Stock | D | 832 | $48.30 - $48.30 | $40,185 |
| 2024-01-25 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2527 | $48.30 - $48.30 | $122,054 |
| 2024-01-04 | SOLENO THERAPEUTICS INC | Yen Kristen
(See Remarks) |
A | Common Stock | A | 24000 | $0.00 - $0.00 | $0 |
| 2024-01-04 | SOLENO THERAPEUTICS INC | Mackaness James H
(Chief Financial Officer) |
A | Common Stock | A | 56000 | $0.00 - $0.00 | $0 |
| 2024-01-04 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(See Remarks) |
A | Common Stock | A | 24000 | $0.00 - $0.00 | $0 |
| 2024-01-04 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(Chief Executive Officer) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2023-12-12 | SOLENO THERAPEUTICS INC | Yen Kristen
(See Remarks) |
S | Common Stock | D | 37829 | $36.64 - $37.76 | $1,412,429 |
| 2023-12-13 | SOLENO THERAPEUTICS INC | Yen Kristen
(See Remarks) |
M | Common Stock | A | 17916 | $2.41 - $2.60 | $45,644 |
| 2023-12-11 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(Chief Executive Officer) |
S | Common Stock | D | 93408 | $35.26 - $37.01 | $3,331,700 |
| 2023-12-11 | SOLENO THERAPEUTICS INC | Mackaness James H
(Chief Financial Officer) |
M | Common Stock | A | 15000 | $2.60 - $2.60 | $38,925 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |